121 related articles for article (PubMed ID: 37130177)
21. Risk factors of non-sentinel lymph node metastasis in breast cancer with 1-2 sentinel lymph node macrometastases underwent total mastectomy: a case-control study.
Huang Z; Wu Z; Zou QQ; Xie YJ; Li LH; Huang YP; Wu FM; Huang D; Pan YH; Yang JR
World J Surg Oncol; 2023 Apr; 21(1):125. PubMed ID: 37024930
[TBL] [Abstract][Full Text] [Related]
22. Quantitative molecular analysis of sentinel lymph node may be predictive of axillary node status in breast cancer classified by molecular subtypes.
Buglioni S; Di Filippo F; Terrenato I; Casini B; Gallo E; Marandino F; Maini CL; Pasqualoni R; Botti C; Di Filippo S; Pescarmona E; Mottolese M
PLoS One; 2013; 8(3):e58823. PubMed ID: 23533593
[TBL] [Abstract][Full Text] [Related]
23. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
[TBL] [Abstract][Full Text] [Related]
24. Comparison of molecular analysis and histopathology for axillary lymph node staging in primary breast cancer: results of the B-CLOSER-I study.
Vegué LB; Rojo F; Hardisson D; Iturriagagoitia AC; Panadés MJ; Velasco A; Bonet EL; Muñoz RC; Polo L;
Diagn Mol Pathol; 2012 Jun; 21(2):69-76. PubMed ID: 22555089
[TBL] [Abstract][Full Text] [Related]
25. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
[TBL] [Abstract][Full Text] [Related]
26. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
[TBL] [Abstract][Full Text] [Related]
28. Detailed evaluation of one step nucleic acid (OSNA) molecular assay for intra-operative diagnosis of sentinel lymph node metastasis and prediction of non-sentinel nodal involvement: experience from a London teaching hospital.
Banerjee SM; Michalopoulos NV; Williams NR; Davidson T; El Sheikh S; McDermott N; Tran-Dang MA; Davison S; Keshtgar MR
Breast; 2014 Aug; 23(4):378-84. PubMed ID: 24630617
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of breast cancer micrometastasis in the sentinel lymph node.
Shimazu K; Noguchi S
Surg Today; 2016 Feb; 46(2):155-60. PubMed ID: 25893770
[TBL] [Abstract][Full Text] [Related]
32. The Use of CYFRA 21-1 for the Detection of Breast Cancer Axillary Lymph Node Metastases in Needle Washouts of Fine-Needle Aspiration Biopsies.
Liscia DS; Detoma P; Zanchetta M; Anrò P; Molinar D; Favettini E; Paduos A
Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):190-195. PubMed ID: 26657871
[TBL] [Abstract][Full Text] [Related]
33. Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer.
Ohi Y; Umekita Y; Sagara Y; Rai Y; Yotsumoto D; Matsukata A; Baba S; Tamada S; Matsuyama Y; Ando M; Sagara Y; Sasaki M; Tsuchimochi S; Tanimoto A; Sagara Y
Br J Cancer; 2012 Oct; 107(8):1239-43. PubMed ID: 22929881
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Choi SH; Barsky SH; Chang HR
Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
[TBL] [Abstract][Full Text] [Related]
35. Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.
Peg V; Espinosa-Bravo M; Vieites B; Vilardell F; Antúnez JR; de Salas MS; Delgado-Sánchez JJ; Pinto W; Gozalbo F; Petit A; Sansano I; Del Mar Téllez M; Rubio IT
Breast Cancer Res Treat; 2013 May; 139(1):87-93. PubMed ID: 23576079
[TBL] [Abstract][Full Text] [Related]
36. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
[TBL] [Abstract][Full Text] [Related]
37. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
38. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
Langer I; Marti WR; Guller U; Moch H; Harder F; Oertli D; Zuber M
Ann Surg; 2005 Jan; 241(1):152-8. PubMed ID: 15622003
[TBL] [Abstract][Full Text] [Related]
39. A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer.
Deambrogio C; Castellano I; Paganotti A; Zorini EO; Corsi F; Bussone R; Franchini R; Antona J; Miglio U; Sapino A; Antonacci C; Boldorini R
J Clin Pathol; 2014 Aug; 67(8):702-6. PubMed ID: 24906358
[TBL] [Abstract][Full Text] [Related]
40. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East.
Imoto S; Hasebe T
Jpn J Clin Oncol; 1999 Jan; 29(1):11-5. PubMed ID: 10073145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
